Skip header and navigation

4 records – page 1 of 1.

Document Type
Table
Review Code
EOC210302 RR Table
Question Submitted
March 30, 2021
Date Completed
April 21, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC210302 RR Table
Question Submitted
March 30, 2021
Date Completed
April 21, 2021
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Healthcare Services
Subject
Vaccines
Vaccination
Risk
Comorbidities
Population
All
Other
vulnerable populations (clinically)
Clinical Setting
Cardiac unit
Community
Dialysis unit
ICU
Long Term Care
Medicine Unit
NICU
Oncology
Primary care
Public Health
Priority Level
Level 3 Two weeks (14 days)
Cite As
Azizian, A; Lee, S; Shumilak, G; Groot, G; Reeder, B; Miller, L; Howell-Spooner, B. What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? 2021 Apr 20, Document no.: EOC210302 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CEST table).
Similar Reviews
INF031801 RR
Related Documents
Documents

EOC210302 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC210902 RR Table
Question Submitted
September 22, 2021
Date Completed
October 7, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC210902 RR Table
Question Submitted
September 22, 2021
Date Completed
October 7, 2021
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Infection Prevention and Control
Subject
Decision Making
Health Planning
Infection Prevention and Control
Vaccination
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 3 Two weeks (14 days)
Related Documents
Documents

EOC210902 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC220503 RR Table
Question Submitted
May 4, 2022
Date Completed
May 24, 2022
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC220503 RR Table
Question Submitted
May 4, 2022
Date Completed
May 24, 2022
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Subject
Infection Prevention and Control
Decision Making
Health Planning
Vaccines
Population
All
Priority Level
Level 3 Two weeks (14 days)
Cite As
Badea, A; Groot, G; Reeder, B; Mueller, M; Miller, L. When should post-COVID infected patients receive booster shots? 2022 May 24, Document no.: EOC220503 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST table).
Related Documents
Documents

EOC220503 RR Table

Download File
Less detail
Document Type
Table
Review Code
INF220501 RR Table
Question Submitted
May 16, 2022
Date Completed
June 6, 2022
Status
3. Completed
Research Team
Infectious Disease
Document Type
Table
Review Code
INF220501 RR Table
Question Submitted
May 16, 2022
Date Completed
June 6, 2022
Status
3. Completed
Research Team
Infectious Disease
Category
Clinical Presentation
Diagnostics
Subject
Immunity
Infection Prevention and Control
Vaccination
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 4 Three weeks (21 days)
Cite As
Groot, G; Reeder, B; Muhajarine, N; Lee, S; Badea, A; Fox, L; Miller, L. What is known about hybrid immunity to COVID-19? 2022 Jun 06, Document no.: INF220501 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST table).
Related Documents
Documents

INF220501 RR Table

Download File
Less detail